Estramustine Phosphate Versus Placebo as Second Line Treatment After Orchiectomy in Patients With Metastatic Prostate Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Estramustine Phosphate Versus Placebo as Second Line Treatment After Orchiectomy in Patients With Metastatic Prostate Cancer

Published:1997-03 Issue: Volume: Page:929-934
ISSN:0022-5347
Container-title:The Journal of Urology
language:en
Short-container-title:The Journal of Urology

Author:

Iversen Peter,Rasmussen Finn,Asmussen Christian,Christensen Ib J.,Eickhoff Jens,Klarskov Peter,Larsen Erik,Mogensen Peter,Mommsen Soren,Rosenkilde Palle

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference18 articles.

1. The Management of Carcinoma of the Prostate after Failed Primary Therapy

2. A Critical Assessment of the Role of Chemotherapy for Endocrine-Resistant Prostatic Carcinoma

3. Is there evidence that chemotherapy is of benefit to patients with carcinoma of the prostate?

4. Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells.

5. Evidence for a non-estrogenic cytostatic effect of estramustine on human prostatic carcinoma cells in vivo

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of hormone refractory prostate cancer;Annals of the College of Surgeons Hong Kong;2004-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP